GDPR has contributed to a decline in the number of healthcare professionals disclosing payments or benefits from the pharma industry, says the Association of the British Pharmaceutical Industry.
Only 55 percent of healthcare professionals receiving a payment or benefit in kind from the pharmaceutical industry in 2015 gave their consent for their details to be published on Disclosure UK, a new analysis by research organisation RAND Europe has revealed.